These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis? Banikazemi M; Desnick RJ Nat Clin Pract Nephrol; 2006 Feb; 2(2):72-3. PubMed ID: 16932395 [No Abstract] [Full Text] [Related]
7. [Fabry's disease. An orphan disease that has found a solution: enzymatic replacement with alpha-galactosidase]. Selgas R; García de Lorenzo A; Valdés F; Beck M Nefrologia; 2001; 21(5):443-7. PubMed ID: 11795012 [No Abstract] [Full Text] [Related]
8. Enzyme replacement therapy and Fabry kidney disease: quo vadis? Warnock DG J Am Soc Nephrol; 2007 May; 18(5):1368-70. PubMed ID: 17429046 [No Abstract] [Full Text] [Related]
12. [Enzyme therapy in Fabry disease: when scarcity of one enzyme illustrates the vulnerability of biotech]. Lidove O; Choukroun G; Bekri S; Viot G; Tsimaratos M; Joly D Presse Med; 2010 May; 39(5):527-9. PubMed ID: 20194001 [No Abstract] [Full Text] [Related]
13. Enzyme replacement in the treatment of Fabry's disease. Is there a point-of-no-return? del Toro N; Milán JA; Palma A Nephrol Dial Transplant; 2004 Apr; 19(4):1018. PubMed ID: 15031378 [No Abstract] [Full Text] [Related]
14. Neurological features of Fabry disease: clinical, pathophysiological aspects and therapy. Bersano A; Lanfranconi S; Valcarenghi C; Bresolin N; Micieli G; Baron P Acta Neurol Scand; 2012 Aug; 126(2):77-97. PubMed ID: 22428782 [TBL] [Abstract][Full Text] [Related]
15. Do we need more intensive enzyme replacement therapy for Anderson-Fabry disease? Basic-Jukic N; Kes P; Mokos I; Coric M Med Hypotheses; 2009 Apr; 72(4):476-7. PubMed ID: 19124204 [No Abstract] [Full Text] [Related]
16. Enzyme replacement therapy and Fabry nephropathy. Warnock DG; Daina E; Remuzzi G; West M Clin J Am Soc Nephrol; 2010 Feb; 5(2):371-8. PubMed ID: 20007680 [TBL] [Abstract][Full Text] [Related]
17. Fabry disease in children and response to enzyme replacement therapy: results from the Fabry Outcome Survey. Ramaswami U; Parini R; Pintos-Morell G; Kalkum G; Kampmann C; Beck M; Clin Genet; 2012 May; 81(5):485-90. PubMed ID: 21457233 [TBL] [Abstract][Full Text] [Related]
19. Fabry disease: is there a role for enzyme replacement therapy? Mehta AB J Intern Med; 2013 Oct; 274(4):329-30. PubMed ID: 23662843 [No Abstract] [Full Text] [Related]
20. Enzyme replacement therapy in Fabry disease in Poland: a position statement. Nowicki M; Bazan-Socha S; Błażejewska-Hyzorek B; Gellert R; Imiela J; Kaźmierczak J; Kłopotowski M; Oko-Sarnowska Z; Pawlaczyk K; Ponikowski P; Sławek J; Sykut-Cegielska J; Witkowski A; Zwolińska D Pol Arch Intern Med; 2020 Jan; 130(1):91-97. PubMed ID: 31868861 [No Abstract] [Full Text] [Related] [Next] [New Search]